Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
BW LPG
BWLP
$3.38B
| $1.46M | ﹤0.01% |
111,828
-77,403
| -41% | -$989K |
|
3127
Mercer International
MERC
$33.8M
| $1.46M | ﹤0.01% |
739,335
+726,120
| +5,495% | +$1.53M |
|
|
AMTM
3128
Amentum Holdings
AMTM
$5.3B
| $1.46M | ﹤0.01% |
50,375
-3,287
| -6% | -$84K |
|
|
CAI
3129
Caris Life Sciences
CAI
$6.27B
| $1.46M | ﹤0.01% |
54,117
+50,940
| +1,603% | +$1.43M |
|
3130
Empire State Realty Trust
ESRT
$836M
| $1.46M | ﹤0.01% |
223,744
+8,316
| +4% | +$59.4K |
|
3131
FuboTV Inc
FUBO
$296M
| $1.46M | ﹤0.01% |
48,236
-2,487
| -5% | -$99.3K |
|
3132
HBT Financial
HBT
$1.35B
| $1.46M | ﹤0.01% |
56,317
+1,732
| +3% | +$42.8K |
|
3133
Annexon
ANNX
$862M
| $1.46M | ﹤0.01% |
289,963
+142,033
| +96% | +$543K |
|
3134
Concentrix
CNXC
$1.52B
| $1.45M | ﹤0.01% |
34,977
-44,009
| -56% | -$1.79M |
|
3135
Navigator Holdings
NVGS
$1.27B
| $1.45M | ﹤0.01% |
83,875
-9,696
| -10% | -$162K |
|
|
PRSU
3136
Pursuit Attractions and Hospitality Inc
PRSU
$1.29B
| $1.45M | ﹤0.01% |
43,123
+13,129
| +44% | +$458K |
|
|
BKV
3137
BKV Corp
BKV
$2.84B
| $1.45M | ﹤0.01% |
53,430
+29,672
| +125% | +$745K |
|
|
TRST
3138
Trustco Bank Corp NY
TRST
$971M
| $1.45M | ﹤0.01% |
35,073
+7,721
| +28% | +$308K |
|
3139
Altimmune
ALT
$560M
| $1.45M | ﹤0.01% |
400,595
+60,312
| +18% | +$263K |
|
|
AIV
3140
Aimco
AIV
$379M
| $1.45M | ﹤0.01% |
243,343
+10,385
| +4% | +$62.2K |
|
3141
Teekay
TK
$1.06B
| $1.44M | ﹤0.01% |
159,950
+86,506
| +118% | +$796K |
|
3142
PDF Solutions
PDFS
$2.13B
| $1.44M | ﹤0.01% |
50,556
+925
| +2% | +$25.6K |
|
|
DEA
3143
Easterly Government Properties
DEA
$1.18B
| $1.44M | ﹤0.01% |
68,008
+8,102
| +14% | +$176K |
|
|
QXO
3144
QXO Inc
QXO
$16.1B
| $1.44M | ﹤0.01% |
74,669
-503,510
| -87% | -$9.65M |
|
3145
CALL
American Tower
AMT
$81.2B
| $1.44M | ﹤0.01% |
8,200
+8,100
| +8,100% | +$1.47M |
|
3146
Middlesex Water
MSEX
$1.11B
| $1.44M | ﹤0.01% |
28,545
+3,341
| +13% | +$180K |
|
3147
PUT
FTAI Aviation
FTAI
$22.2B
| $1.44M | ﹤0.01% |
+7,300
| New | +$1.24M |
|
3148
CytomX Therapeutics
CTMX
$730M
| $1.43M | ﹤0.01% |
336,525
+335,035
| +22,486% | +$1.27M |
|
|
BOW
3149
Bowhead Specialty Holdings
BOW
$1.1B
| $1.43M | ﹤0.01% |
50,182
-34,310
| -41% | -$910K |
|
3150
CALL
Mastercard
MA
$497B
| $1.43M | ﹤0.01% |
2,500
| – | – |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.